We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Recommendations to Improve Drug Development Process
FDA Issues Recommendations to Improve Drug Development Process
August 19, 2005
Traditional drug development models no longer are effective for today's pharmaceutical firms, according to an FDA report that identifies opportunities for improving the R&D process, including through greater sharing of "precompetitive" data and earlier testing of drug candidates in humans.